Your account is not claimed yet. You can sign up with ORCID to claim your account.

Pieter Johan Adam Eichhorn (Pieter J A Eichhorn)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 9

Top Venues

EMBO reports

Nature communications

SLAS technology

Nature reviews. Cancer

Curtin University

Newcastle University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Curtin University Jan 1o 2018

Australia

Associate Professor :: School of Pharmacy and Biomedical Sciences

Education History

Newcastle University Aug 1o 1996 - Aug 1o 2000

United Kingdom

PHD :: Medicine

Publications

Grant Dewson, Pieter Johan Adam Eichhorn, David Komander
Deubiquitinases in cancer. Nature reviews. Cancer (2023)
Sarah Christine Elisabeth Wright, Natali Vasilevski, Violeta Serra, Jordi Rodon, Pieter Johan Adam Eichhorn
Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses, Drug Tolerance and Cellular Plasticity. Cancers 13 (7) (2021)
Sarah Kit Leng Lui, Prasanna Vasudevan Iyengar, Patrick Jaynes, Zul Fazreen Bin Adam Isa, Brendan Pang, Tuan-Zea Tan, Pieter Johan Adam Eichhorn
USP26 regulates TGF-β signaling by deubiquitinating and stabilizing SMAD7. EMBO reports 21 (1) (2019)
Wen Jing Sim, Prasanna Vasudevan Iyengar, Dilraj Lama, Sarah Kit Leng Lui, Hsien Chun Ng, Lior Haviv-Shapira, Eytan Domany, Dennis Kappei, Tuan-Zea Tan, Azad Saei, Patrick William Jaynes, Chandra Shekhar Verma, Alan Prem Kumar, Mathieu Rouanne, Hong Koo Ha, Camelia Radulescu, Peter Ten Dijke, Pieter Johan Adam Eichhorn, Jean-Paul Thiery
Author Correction: c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression. Nature communications 10 (1) (2019)
Wen Jing Sim, Prasanna Vasudevan Iyengar, Dilraj Lama, Sarah Kit Leng Lui, Hsien Chun Ng, Lior Haviv-Shapira, Eytan Domany, Dennis Kappei, Tuan-Zea Tan, Azad Saei, Patrick William Jaynes, Chandra Shekhar Verma, Alan Prem Kumar, Mathieu Rouanne, Hong Koo Ha, Camelia Radulescu, Peter Ten Dijke, Pieter Johan Adam Eichhorn, Jean-Paul Thiery
c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression. Nature communications 10 (1) (2019)
Azad Saei, Pieter Johan Adam Eichhorn
Ubiquitination and adaptive responses to BRAF inhibitors in Melanoma. Molecular & cellular oncology 5 (5) (2018)
Azad Saei, Marta Palafox, Touati Benoukraf, Nishi Kumari, Patrick William Jaynes, Prasanna Vasudevan Iyengar, Eva Muñoz Couselo, Paolo G Nuciforo, Javier Cortés, Christopher Nötzel, Nesaretnam Barr Kumarakulasinghe, John Lalith Charles Richard, Zul Fazreen Bin Adam Isa, Brendan Pang, Marta Guzman, Zhou Siqin, Henry Yang, Wai Leong Tam, Violeta Serra, Pieter Johan Adam Eichhorn
Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies. The Journal of experimental medicine 215 (7) (2018)
John Lalith Charles Richard, Pieter Johan Adam Eichhorn
Platforms for Investigating LncRNA Functions. SLAS technology 23 (6) (2018)
Sarah Kit Leng Lui, Prasanna Vasudevan Iyengar, Patrick Jaynes, Zul Fazreen Bin Adam Isa, Brendan Pang, Tuan Zea Tan, Pieter Johan Adam Eichhorn
USP26 regulates TGF-β signaling by deubiquitinating and stabilizing SMAD7. EMBO reports 18 (5) (2017)

Pieter Johan Adam Eichhorn.css-eqlu8i{font-size:small;padding-left:4px;} (Pieter J A Eichhorn)

Publication Activity (10 Years)

Top Topics

Top Venues

Pieter Johan Adam Eichhorn (Pieter J A Eichhorn)